Re: Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer Editorial Comment

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 200卷 / 03期
关键词：
D O I：
10.1016/j.juro.2018.05.116
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：498 / 499
页数：2
相关论文
共 50 条
  • [1] Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
    Spratt, Daniel E.
    Zhang, Jingbin
    Santiago-Jimenez, Maria
    Dess, Robert T.
    Davis, John W.
    Den, Robert B.
    Dicker, Adam P.
    Kane, Christopher J.
    Pollack, Alan
    Stoyanova, Radka
    Abdollah, Firas
    Ross, Ashley E.
    Cole, Adam
    Uchio, Edward
    Randall, Josh M.
    Hao Nguyen
    Zhao, Shuang G.
    Mehra, Rohit
    Glass, Andrew G.
    Lam, Lucia L. C.
    Chelliserry, Jijumon
    du Plessis, Marguerite
    Choeurng, Voleak
    Aranes, Maria
    Kolisnik, Tyler
    Margrave, Jennifer
    Alter, Jason
    Jordan, Jennifer
    Buerki, Christine
    Yousefi, Kasra
    Haddad, Zaid
    Davicioni, Elai
    Trabulsi, Edouard J.
    Loeb, Stacy
    Tewari, Ashutosh
    Carroll, Peter R.
    Weinmann, Sheila
    Schaeffer, Edward M.
    Klein, Eric A.
    Karnes, R. Jeffrey
    Feng, Felix Y.
    Nguyen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 581 - +
  • [2] Development and validation of a novel clinical-genomic risk group classification for prostate cancer incorporating genomic and clinicopathologic risk
    Spratt, Daniel Eidelberg
    Zhang, Jingbin
    Santiago-Jimenez, Maria
    Davis, John W.
    Den, Robert Benjamin
    Dicker, Adam
    Kane, Christopher J.
    Pollack, Alan
    Ross, Ashley
    du Plessis, Marguerite
    Choeurng, Voleak
    Yousefi, Kasra
    Haddad, Zaid
    Davicioni, Elai
    Weinmann, Sheila
    Schaeffer, Edward M.
    Klein, Eric A.
    Karnes, R. Jeffrey
    Feng, Felix Yi-Chung
    Nguyen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Development and Validation of a Novel Clinical-Genomic Risk Group Classification for Prostate Cancer Incorporating Genomic and Clinicopathologic Risk
    Spratt, D. E.
    Dess, R. T.
    Zhang, J.
    Santiago-Jimenez, M.
    Davis, J. W.
    Den, R. B.
    Dicker, A. P.
    Kane, C. J.
    Pollack, A.
    Ross, A. E.
    du Plessis, M.
    Choeurng, V.
    Haddad, Z.
    Davicioni, E.
    Weinmann, S.
    Schaeffer, E. M.
    Klein, E. A.
    Karnes, R. J.
    Feng, F. Y.
    Nguyen, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S97 - S97
  • [4] Clinical-genomic Risk Group Classification of Suspicions Lesions on Prostate mpMRI
    Zavala-Romero, O.
    Pollack, A.
    Kwon, D.
    Breto, A. L.
    Davicioni, E.
    Abramowitz, M. C.
    Dal Pra, A.
    Punnen, S.
    Stoyanova, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S135 - S136
  • [5] Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI
    Stoyanova, Radka
    Zavala-Romero, Olmo
    Kwon, Deukwoo
    Breto, Adrian L.
    Xu, Isaac R.
    Algohary, Ahmad
    Alhusseini, Mohammad
    Gaston, Sandra M.
    Castillo, Patricia
    Kryvenko, Oleksandr N.
    Davicioni, Elai
    Nahar, Bruno
    Spieler, Benjamin
    Abramowitz, Matthew C.
    Dal Pra, Alan
    Parekh, Dipen J.
    Punnen, Sanoj
    Pollack, Alan
    CANCERS, 2023, 15 (21)
  • [6] UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSITICATION IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER
    Udit, Singhal
    Todd, Morgan M.
    Ralph, Jiang
    Matthew, Schipper
    Elizabeth, Chase
    James, Proudfoot
    Elai, Davicioni
    Krithika, Suresh
    William, Jackson C.
    Robert, Dess T.
    Daniel, Spratt E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S84 - S85
  • [7] UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSTICATION IN PROSTATE CANCER
    Singhal, Udit
    Jiang, Ralph
    Schipper, Matthew
    Proudfoot, James
    Chase, Elisabeth
    Suresh, Krithika
    Davicioni, Elai
    Jackson, William C.
    Spratt, Daniel E.
    Dess, Robert T.
    Morgan, Todd M.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E893 - E893
  • [8] Clinical-genomic sub-classification of high-risk prostate cancer: Implications for tailoring therapy and clinical trial design
    Muralidhar, Vinayak
    Alshalalfa, Mohammed
    Spratt, Daniel Eidelberg
    Liu, Yang
    Karnes, R. Jeffrey
    Schaeffer, Edward M.
    Davicioni, Elai
    Feng, Felix Y.
    Klein, Eric A.
    Tosoian, Jeffrey J.
    Berlin, Alejandro
    Den, Robert Benjamin
    Nguyen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design
    Muralidhar, V.
    Alshalalfa, M.
    Spratt, D. E.
    Liu, S.
    Karnes, R. J.
    Schaeffer, E. M.
    Davicioni, E.
    Feng, F. Y.
    Klein, E. A.
    Tosoian, J.
    Berlin, A.
    Den, R. B.
    Nguyen, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E854 - E854
  • [10] Re: Treatment Patterns for Older Veterans with Localized Prostate Cancer Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2016, 196 (01): : 107 - 108
12345